PureTech Health plc
PRTC
Price:
$19.415
Market Cap:
$464.80M
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and psychosis in Alzheimer's disease; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; an immunomodulation platform to treat chronic and acute inflammatory disorders; oral therapies based on defined consortia of bacteria is isolated from the human microbiome...[Read more]
Industry
Biotechnology
IPO Date
2020-11-16
Stock Exchange
NASDAQ
Ticker
PRTC
The ROE as of September 2024 (TTM) for PureTech Health plc (PRTC) is -29.01%
According to PureTech Health plc’s latest financial reports and current stock price. The company's current ROE is -29.01%. This represents a change of 272.26% compared to the average of -7.79% of the last 4 quarters.
PureTech Health plc (PRTC) Historical ROE (quarterly & annually)
How has PRTC ROE performed in the past?
The mean historical ROE of PureTech Health plc over the last ten years is -3.74%. The current -29.01% ROE has changed 675.32% with respect to the historical average. Over the past ten years (40 quarters), PRTC's ROE was at its highest in in the December 2019 quarter at 59.59%. The ROE was at its lowest in in the September 2014 quarter at -57.36%.
Average
-3.74%
Median
-12.36%
Minimum
-27.46%
Maximum
63.04%
PureTech Health plc (PRTC) ROE by Quarter and Year
Discovering the peaks and valleys of PureTech Health plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 107.10%
Maximum Annual ROE = 63.04%
Minimum Annual Increase = -1649.11%
Minimum Annual ROE = -27.46%
| Year | ROE | Change |
|---|---|---|
| 2023 | -14.16% | 107.10% |
| 2022 | -6.84% | -35.30% |
| 2021 | -10.57% | -1649.11% |
| 2020 | 0.68% | -98.92% |
| 2019 | 63.04% | -497.87% |
| 2018 | -15.84% | -210.00% |
| 2017 | 14.40% | -152.45% |
| 2016 | -27.46% | 57.64% |
| 2015 | -17.42% | -25.11% |
| 2014 | -23.26% | -104.78% |
PureTech Health plc (PRTC) Average ROE
How has PRTC ROE performed in the past?
The current ROE of PureTech Health plc (PRTC) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.52%
5-year avg
6.43%
10-year avg
-3.74%
PureTech Health plc (PRTC) ROE vs. Peers
How is PRTC’s ROE compared to its peers?
PureTech Health plc’s ROE is greater than Molecular Partners AG (-33.08%), greater than MediciNova, Inc. (-13.37%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), less than Champions Oncology, Inc. (323.52%), greater than Cyteir Therapeutics, Inc. (-23.13%), greater than Eliem Therapeutics, Inc. (-47.03%), less than Opthea Limited (360.05%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.31%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Janux Therapeutics, Inc. (-8.78%), greater than Rezolute, Inc. (-60.90%), greater than Nuvation Bio Inc. (-98.79%), greater than Magenta Therapeutics, Inc. (-61.71%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Graphite Bio, Inc. (-57.96%),
| Company | ROE | Market cap |
|---|---|---|
| -33.08% | $160.66M | |
| -13.37% | $76.02M | |
| -122.97% | $51.87M | |
| 323.52% | $58.18M | |
| -23.13% | $108.71M | |
| -47.03% | $535.14M | |
| 360.05% | $516.67M | |
| -47.31% | $234.15M | |
| -42.61% | $581.30M | |
| -8.78% | $2.52B | |
| -60.90% | $269.59M | |
| -98.79% | $719.91M | |
| -61.71% | $42.44M | |
| -47.64% | $8.20M | |
| -57.96% | $185.19M |
Build a custom stock screener for PureTech Health plc (PRTC) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PureTech Health plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
PureTech Health plc (PRTC) and other stocks custom spreadsheet templates
The easiest way to analyze a company like PureTech Health plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is PureTech Health plc's ROE?
How is the ROE calculated for PureTech Health plc (PRTC)?
What is the highest ROE for PureTech Health plc (PRTC)?
What is the 3-year average ROE for PureTech Health plc (PRTC)?
What is the 5-year average ROE for PureTech Health plc (PRTC)?
How does the current ROE for PureTech Health plc (PRTC) compare to its historical average?